Skye Bioscience, Inc. Accounts Payable
Skye Bioscience, Inc. (SKYE) had Accounts Payable of $4.28 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-14
- 2026-06-30: Accounts Payable, Current $4.28M.
- 2026-03-31: Accounts Payable, Current $3.94M.
- 2025-12-31: Accounts Payable, Current $2.03M.
- 2025-09-30: Accounts Payable, Current $2.83M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $4.28M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $3.94M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $2.03M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $2.83M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $3.22M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $1.71M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $569.25K 10-K · filed 2026-03-10 |
| 2024-09-30 | $780.02K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.08M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $1.10M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $1.16M 10-Q · filed 2024-11-07 |
| 2023-09-30 | $1.63M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $1.55M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $1.22M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $1.67M 10-Q · filed 2023-11-14 |
| 2022-09-30 | $2.07M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.44M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $878.72K 10-Q · filed 2022-05-06 |
| 2021-12-31 | $897.88K 10-K · filed 2023-03-31 |
| 2021-09-30 | $318.98K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $382.14K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $499.85K 10-Q · filed 2021-05-07 |
| 2020-12-31 | $364.34K 10-K · filed 2022-03-28 |
| 2020-09-30 | $731.63K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $1.10M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $937.27K 10-Q · filed 2020-05-08 |
| 2019-12-31 | $129.81K 10-K · filed 2021-03-02 |
| 2019-09-30 | $206.93K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $73.46K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $168.28K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $15.60K 10-K · filed 2020-03-23 |
| 2018-09-30 | $45.50K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $11.92K 10-Q · filed 2018-08-10 |
| 2018-03-31 | $98.76K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $100.92K 10-K · filed 2019-03-14 |
| 2017-09-30 | $990.12K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $679.49K 10-Q · filed 2017-08-11 |
| 2017-03-31 | $227.16K 10-Q · filed 2017-05-12 |
| 2016-12-31 | $274.65K 10-K · filed 2018-03-19 |
| 2016-09-30 | $387.37K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $183.22K 10-Q · filed 2016-08-12 |
| 2016-03-31 | $137.37K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $125.36K 10-K · filed 2017-03-10 |
| 2015-09-30 | $132.23K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $285.89K 10-Q · filed 2015-08-14 |
| 2015-03-31 | $388.11K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $409.50K 10-K · filed 2016-03-21 |
| 2013-12-31 | $2.15K 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |